Vaccines Market Research, Industry Trends, Market Share


Published: 08/08/2018
Pages: 264
Full Study Price: US$ 4,500

The global market for human vaccines experienced strong growth through 2017 with continued expansion of major products. Through 2024, growth will be fuelled by favorable demographics (population growth, rising life expectancy), continued new product introductions, indication expansions for some products and rising usage, particularly in India and China. However, mitigating against growth will be continuing concerns about vaccine safety and refusal to immunize. This report contains an expanded section on this topic.

A mainstay of preventative medicine for over 70 years, a vaccine is a biological preparation used to trigger an immune response to a selected disease. The term derives from Edward Jenner's use of cowpox ("vacca" means cow in Latin), which, when administered to humans, protected them against smallpox. Vaccines can be either prophylactic or therapeutic.

Because of the large number of deadly diseases that have been virtually eliminated through the proliferation of effective vaccines, vaccination is generally viewed as one of the greatest public health achievements during the 20th century. As a result of widespread public vaccination, vaccine-preventable diseases and their resulting deaths are now rare in the developed nations and declining worldwide. Immunizations have eradicated smallpox; eliminated poliomyelitis in the Americas; and controlled measles, rubella, tetanus, diphtheria, Haemophilus influenzae type b, and other infectious diseases.

Our Simple Buying Process

Choose License and Add
This Report To Your Cart.

Register, Checkout
and Verify Payment.

Receive Notification When
Your Report Is Available.

Table Of Contents

  • Executive Summary
    • The Global Vaccines Industry
    • Scope and Methodology
    • Market Estimates and Forecasts
  • Introduction to Vaccines
    • Introduction
      • Table Global Morbidity of Vaccine Preventable Diseases in 1990 vs. 2016
    • A Brief History: The Development of Vaccines
    • The Human Immune System
    • Vaccine Mechanism of Action
    • Types of Vaccines
      • Attenuated (Weakened) Live Viruses
        • Table Attenuated Virus Production
      • Killed (Inactivated) Viruses
      • Toxoid Vaccines
      • Genetically Engineered/Modified Vaccines
    • Vaccine Approval Process
      • Table VAERS Table of Reportable Events Following Vaccination
  • Pediatric Preventative Vaccines
    • Introduction
      • Table Global Child Immunization Rates for Vaccines Recommended by the WHO, 2016
    • Childhood Immunization in the United States
      • Table Immunization Profile of the United States - Population by Age Group, Number of Vaccine- Preventable Diseases Reported by Disease, 1990–2014
      • Childhood Immunization Rates
      • Challenges to the Vaccine Delivery System
      • Recommended Childhood Immunization Schedule
      • State Immunization Recommendations
      • United Nations Initiatives
    • Pediatric Vaccine Products
      • Addiction
      • BCG
      • Dengue Fever
      • Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio
      • Haemophilus Influenzae Type B
      • Hand, Foot & Mouth Disease
      • Hepatitis A
      • Influenza
      • Measles, Mumps and Rubella
      • Meningococcal Disease
      • Pneumococcal Conjugate
      • Rotavirus
      • Respiratory Syncytial Virus
      • Varicella
    • Pediatric Vaccines in Development
      • Table Selected Pediatric Vaccines in Development, 2018
    • The World Market for Pediatric Preventive Vaccines
      • Total Market Size and Forecast
        • Table World Market for Pediatric Preventive Vaccines by Type (Hep, HiB, MMR, Combinations, Pneumococcal Disease, Polio, Varicella, Others) 2015–2024, in $ Millions
        • Table Growth of World Market for Pediatric Preventative Vaccines by Type (Hep, HiB, MMR, Combinations, Pneumococcal Disease, Polio, Varicella, Others) 2015–2024
        • Table Market Share of Pediatric Preventative Vaccines by Type, 2017 (Hep, HiB, MMR, Combinations, Pneumococcal Disease, Polio, Varicella, Others) (%)
        • Table Market Share of Pediatric Preventative Vaccines by Type, 2024 (Hep, HiB, MMR, Combinations, Pneumococcal Disease, Polio, Varicella, Others) (%)
        • Table World Market for Pediatric Preventative Vaccines by Region (U.S., North America/Caribbean, South America, EU, Japan, India, China, Rest of World) 2015–2024, in $ Millions
        • Table Growth of World Market for Pediatric Preventative Vaccines by Region (U.S., North America/Caribbean, South America, EU, Japan, India, China, Rest of World) 2015–2024
      • Hepatitis Vaccine Market
        • Table World Pediatric Hepatitis Vaccine Market, 2015 – 2024 ($ Millions)
      • Haemophilus Influenzae Type B Vaccine Market
        • Table World Hib Vaccine Market, 2015-2024 ($ Millions)
      • Measles, Mumps and Rubella Vaccines
        • Table World MMR Vaccine Market, 2015-2024 ($ Millions)
      • Combination Vaccines Market
        • Table World Pediatric Combination Vaccine Market, 2015-2024 ($ Millions)
      • Pneumococcal Vaccine
        • Table World Pediatric Pneumococcal Vaccine Market, 2015-2024 ($ Millions)
      • Poliovirus Vaccine
        • Table World Poliovirus Vaccine Market, 2015-2024 ($ Millions)
      • Varicella Vaccines
        • Table World Pediatric Varicella Vaccine Market, 2015-2024 ($ Millions)
      • Other Pediatric Vaccines
        • Table World Other Pediatric Vaccine Market, 2015-2024 ($ Millions)
  • Adult Preventative Vaccines
    • Introduction
    • Global Influenza Surveillance Program
      • U.S. Surveillance
    • Recommended Adult Immunizations
      • Table U.S. Influenza Vaccine Effectiveness, 2004 – 2018 (%)
      • WHO International Health Regulations
    • Adult Vaccine Products
      • BCG
      • Cervical Cancer
        • Table Initiatives to Require HPV Vaccination by U.S. State, 2018
      • Cholera
      • Diphtheria-Tetanus
      • Ebola
      • Hepatitis
      • Influenza
        • Table U.S. Flu Season Severity from 2008 to 2018
        • Table WHO Pandemic Classification Schedule
      • Japanese Encephalitis
      • Nosocomial Infections
      • Pneumococcal Disease
      • Rabies
      • Shingles
      • Typhoid Fever
      • Yellow Fever
    • Adult Vaccines in Development
      • Table Selected Adult Vaccines in Development, 2018
    • The World Market for Adult Preventive Vaccines
      • Total Market Size and Forecast
        • Table World Market Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/Other) 2015–2024, in $ Millions
        • Table Growth of World Market for Adult Preventive Vaccines by Type (Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel/Other) 2015–2024 ($ Millions)
        • Table Market Share of Adult Preventative Vaccines by Type, 2017 (%) (Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel/Other)
        • Table Market Share of Adult Preventative by Type, 2024 (%) (Cervical Cancer, Hepatitis, Influenza, Pneumococcal, Travel/Other)
        • Table World Market for Adult Preventative Vaccines by Region (U.S., North America/Caribbean, South America, EU, Japan, India, China, Rest of World) 2015–2024, in $ Millions
        • Table Growth of World Market for Adult Preventative Vaccines by Region (U.S., North America/Caribbean, South America, EU, Japan, India, China, Rest of World) 2015–2024 ($ Millions)
      • Cervical Cancer Market
        • Table World Cervical Cancer Vaccine Market, 2015-2024 ($ Millions)
      • Hepatitis Market
        • Table World Adult Hepatitis Preventative Vaccine Market, 2015-2024 ($ Millions)
      • Influenza Vaccine Market
        • Table World Adult Influenza Preventative Vaccine Market, 2015-2024 ($ Millions)
        • Table Estimated World Population by Region and Selected Age Group, 2018, in Millions
      • Pneumococcal Vaccine Market
        • Table World Adult Pneumococcal Preventative Vaccine Market, 2015-2024 ($ Millions)
        • Table U.S. Seasonal Influenza Vaccination by Age Group and Season, 2009-2016
      • Travel and Other Vaccine Market
        • Table World Adult Travel and Other Preventative Vaccine Market, 2015-2024 ($ Millions)
  • Total Vaccines Market
    • Trends Driving the Vaccines Market
      • Table Sales Growth of Vaccines vs. Pharmaceuticals, 2015-2024
    • Market Size and Forecast
      • Table Total World Market for Preventive Vaccines by Type, 2015–2024, in $ Millions
      • Table Total World Market for Vaccines by Type, 2015-2024 (Pediatric, Adult) ($ Millions)
      • Table World Market for Vaccines Share by Type, 2015 (Pediatric, Adult) (%)
      • Table World Market for Vaccines Share by Type, 2024 (Pediatric, Adult) (%)
      • Vaccine Sales by Region
        • Table World Market for Preventative Vaccines by Region (U.S., North America/Caribbean, South America, EU, Japan, India, China, Rest of World) 2015–2024, in $ Millions
      • Vaccine Market Competitors
        • Table Major Manufacturers' Shares of the World Vaccine Market, 2017 (%, $ Millions)
        • Table 2017 World Vaccines Market Share, by Leading Competitors (%)
      • Pediatric Vaccines
        • Table Major Manufacturers' Shares of the World Pediatric Preventative Vaccine Market, 2017 (%, $ Millions)
        • Table 2017 World Pediatric Preventative Vaccines Market Share, by Leading Competitors (%)
      • Adult Vaccines
        • Table Major Manufacturers' Shares of the World Adult Preventative Vaccine Market, 2017 (%, $ Millions)
        • Table 2017 World Adult Preventative Vaccines Market Share, by Leading Competitors (%)
  • Issues and Trends
    • Overview
    • Rising Life Expectancy
    • Increasing Obesity
    • Addiction Epidemic
    • Growing Out of Pocket Spending on Healthcare
    • Health Insurance Changes in the U.S.
      • Affordable Care Act Changes
      • Reimbursement Changes and Value-Based Care
    • Decentralization of Healthcare Services
      • Urgent Care Centers
      • Retail Clinics
    • Austerity Programs in Europe
      • UK
      • Other Nations
    • Global Healthcare Mergers and Acquisitions
      • Table Total U.S. Healthcare M&A Deal Value, 2009–2017, in $ Billions
    • Vaccine Safety
      • Data
      • Refusal to Immunize
        • Table Refusal to Vaccinate Form
      • Post-Licensure Surveillance
      • The Vaccine Injury Compensation Program
      • World Health Organization
      • Other Initiatives
    • Pricing Pressure
      • Cost of Vaccines in the United States
    • Vaccine Shortages
      • Preventing Shortages in the Developed Countries
      • Preventing Shortages in Developing Nations
        • Table R&D on Major Developing Nations Vaccine-Preventable Pathogens, 2018
        • Table Access to Vaccines Index, 2017
    • U.S. National Vaccine Plan
    • Vaccines and Bioterrorism
      • Project Bioshield Act
        • Table Selected Companies/Laboratories Developing Biodefense Vaccines, 2018
      • National Bio and Agro-Defense Facility
      • Vaccine Treatment and Evaluation Units
      • Anthrax
      • Smallpox
    • New Disease Threats
      • Table Vaccine-Preventable Diseases, August 2018
    • Stimulating Vaccine Development
      • Global Health Vaccine Center of Innovation
      • Human Vaccines Project
    • Innovations in Vaccine Delivery Systems
      • Mucosal Delivery
      • Intranasal Delivery
      • Microneedles
  • Company Profiles
    • Bavarian Nordic A/S
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • Bharat Biotech
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • Crucell /Johnson & Johnson
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • CSL Limited
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • Daiichi Sankyo Co. Ltd.
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • Emergent Biosolutions
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • GlaxoSmithKline
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • Hawaii Biotech
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • Medimmune
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • Merck & Co. Inc.
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • Mymetics
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • PaxVax
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • Pfizer
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • Sanofi Pasteur
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • Serum Institute of India Pvt. Ltd.
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • Soligenix
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • Takeda Pharmaceutical Co. Ltd.
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information
    • Valneva
      • History and Lines of Business
      • Strategic Alliances
      • Vaccine Products
      • Financial Information